Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Three artificial intelligence data challenges based on CT and ultrasound.
Lassau N, Bousaid I, Chouzenoux E, Verdon A, Balleyguier C, Bidault F, Mousseaux E, Harguem-Zayani S, Gaillandre L, Bensalah Z, Doutriaux-Dumoulin I, Monroc M, Haquin A, Ceugnart L, Bachelle F, Charlot M, Thomassin-Naggara I, Fourquet T, Dapvril H, Orabona J, Chamming's F, El Haik M, Zhang-Yin J, Guillot MS, Ohana M, Caramella T, Diascorn Y, Airaud JY, Cuingnet P, Gencer U, Lawrance L, Luciani A, Cotten A, Meder JF. Lassau N, et al. Among authors: lawrance l. Diagn Interv Imaging. 2021 Nov;102(11):669-674. doi: 10.1016/j.diii.2021.06.005. Epub 2021 Jul 24. Diagn Interv Imaging. 2021. PMID: 34312111 Free article.
Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker.
Naccache R, Belkouchi Y, Lawrance L, Benatsou B, Hadchiti J, Cournede PH, Ammari S, Talbot H, Lassau N. Naccache R, et al. Among authors: lawrance l. Cancers (Basel). 2022 Mar 4;14(5):1337. doi: 10.3390/cancers14051337. Cancers (Basel). 2022. PMID: 35267645 Free PMC article.
An artificial intelligence model predicts the survival of solid tumour patients from imaging and clinical data.
Schutte K, Brulport F, Harguem-Zayani S, Schiratti JB, Ghermi R, Jehanno P, Jaeger A, Alamri T, Naccache R, Haddag-Miliani L, Orsi T, Lamarque JP, Hoferer I, Lawrance L, Benatsou B, Bousaid I, Azoulay M, Verdon A, Bidault F, Balleyguier C, Aubert V, Bendjebbar E, Maussion C, Loiseau N, Schmauch B, Sefta M, Wainrib G, Clozel T, Ammari S, Lassau N. Schutte K, et al. Among authors: lawrance l. Eur J Cancer. 2022 Oct;174:90-98. doi: 10.1016/j.ejca.2022.06.055. Epub 2022 Aug 16. Eur J Cancer. 2022. PMID: 35985252 Free article.
Generative adversarial networks (GAN)-based data augmentation of rare liver cancers: The SFR 2021 Artificial Intelligence Data Challenge.
Mulé S, Lawrance L, Belkouchi Y, Vilgrain V, Lewin M, Trillaud H, Hoeffel C, Laurent V, Ammari S, Morand E, Faucoz O, Tenenhaus A, Cotten A, Meder JF, Talbot H, Luciani A, Lassau N. Mulé S, et al. Among authors: lawrance l. Diagn Interv Imaging. 2023 Jan;104(1):43-48. doi: 10.1016/j.diii.2022.09.005. Epub 2022 Oct 5. Diagn Interv Imaging. 2023. PMID: 36207277 Free article.
Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs.
Decazes P, Ammari S, De Prévia A, Mottay L, Lawrance L, Belkouchi Y, Benatsou B, Albiges L, Balleyguier C, Vera P, Lassau N. Decazes P, et al. Among authors: lawrance l. Diagnostics (Basel). 2023 Jan 5;13(2):205. doi: 10.3390/diagnostics13020205. Diagnostics (Basel). 2023. PMID: 36673015 Free PMC article.
Synthetic MR image generation of macrotrabecular-massive hepatocellular carcinoma using generative adversarial networks.
Couteaux V, Zhang C, Mulé S, Milot L, Valette PJ, Raynaud C, Vlachomitrou AS, Ciofolo-Veit C, Lawrance L, Belkouchi Y, Vilgrain V, Lewin M, Trillaud H, Hoeffel C, Laurent V, Ammari S, Morand E, Faucoz O, Tenenhaus A, Talbot H, Luciani A, Lassau N, Lazarus C. Couteaux V, et al. Among authors: lawrance l. Diagn Interv Imaging. 2023 May;104(5):243-247. doi: 10.1016/j.diii.2023.01.003. Epub 2023 Jan 20. Diagn Interv Imaging. 2023. PMID: 36681532 Free article.
Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy.
Belkouchi Y, Talbot H, Lassau N, Lawrance L, Farhane S, Feki-Mkaouar R, Hadchiti J, Dawi L, Vibert J, Cournède PH, Cousteix C, Mazza C, Kind M, Italiano A, Marabelle A, Ammari S, Champiat S. Belkouchi Y, et al. Among authors: lawrance l. Clin Cancer Res. 2023 Apr 14;29(8):1528-1534. doi: 10.1158/1078-0432.CCR-22-0890. Clin Cancer Res. 2023. PMID: 36719966
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer.
Decazes P, Ammari S, Belkouchi Y, Mottay L, Lawrance L, de Prévia A, Talbot H, Farhane S, Cournède PH, Marabelle A, Guisier F, Planchard D, Ibrahim T, Robert C, Barlesi F, Vera P, Lassau N. Decazes P, et al. Among authors: lawrance l. J Immunother Cancer. 2023 Sep;11(9):e007315. doi: 10.1136/jitc-2023-007315. J Immunother Cancer. 2023. PMID: 37678919 Free PMC article.
21 results